[Travel abroad: gammaglobulin or a vaccine against hepatitis A?]

Subtypes of Hepatitis B Antigen in Blood Donors and Post-transfusion Hepatitis: Clinical and Epidemiological Aspects.

British medical journal·2010

Hepatitis A booster vaccination: is there a need?

Lancet (London, England)·2003

[New and re-emergent epidemics in the changing surrounding world].

Lakartidningen·1999

Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine.

Vaccine·1999

Report from Working Group 3 (the Czech Republic, Denmark, Finland, Norway, The Netherlands, Slovakia, Sweden and the UK).

Vaccine·1999

Why the Scandinavian countries have not implemented universal vaccination against hepatitis B.

Vaccine·1999

[Upper tract urothelial carcinoma - regional differences observed in several quality indicators].

Lakartidningen·2026

[Rare manifestations of giant cell arteritis].

Lakartidningen·2026

[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].

Lakartidningen·2026

[The Swedish Neonatal Quality Register (SNQ) - a complete register for a complex chain of events].

Lakartidningen·2026

[Postoperative atrial fibrillation after open heart surgery].

Lakartidningen·2026

[Interaction between psychotic patients and AI-driven chatbots].

Lakartidningen·2026

M184V: The Major Determinant of Cooperative ISL Resistance When in Combination with Multiple TAM2 Mutations in HIV-1 Subtype C.

Viruses·2026

Longitudinal Changes in IgG N-glycome Are Associated with Disease Severity and Mortality in COVID-19 Patients.

Viruses·2026

Stepwise Evolution of Immunodeficient Mouse Models: Focus on NCG Strains and Their Applications in Humanized Immune System Research.

Vaccines·2026

Impact of the COVID-19 Pandemic on Routine Adult Vaccination in Primary Care: A Multicenter Interrupted Time Series Analysis.

Vaccines·2026

Towards Precision Medicine in Inflammatory Bowel Diseases: Pharmacogenetic Predictors of Ustekinumab Effectiveness and Persistence.

Pharmaceuticals (Basel, Switzerland)·2026

Targeting HMGB1 for Renal Ischemia and Reperfusion Injury: Mechanisms and Therapeutic Strategies.

Pharmaceuticals (Basel, Switzerland)·2026

Related Experiment Videos

[Travel abroad: gammaglobulin or a vaccine against hepatitis A?]

Related Concept Videos

Subtypes of Hepatitis B Antigen in Blood Donors and Post-transfusion Hepatitis: Clinical and Epidemiological Aspects.

Hepatitis A booster vaccination: is there a need?

[New and re-emergent epidemics in the changing surrounding world].

Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine.

Report from Working Group 3 (the Czech Republic, Denmark, Finland, Norway, The Netherlands, Slovakia, Sweden and the UK).

Why the Scandinavian countries have not implemented universal vaccination against hepatitis B.

[Upper tract urothelial carcinoma - regional differences observed in several quality indicators].

[Rare manifestations of giant cell arteritis].

[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].

[The Swedish Neonatal Quality Register (SNQ) - a complete register for a complex chain of events].

[Postoperative atrial fibrillation after open heart surgery].

[Interaction between psychotic patients and AI-driven chatbots].

M184V: The Major Determinant of Cooperative ISL Resistance When in Combination with Multiple TAM2 Mutations in HIV-1 Subtype C.

Longitudinal Changes in IgG N-glycome Are Associated with Disease Severity and Mortality in COVID-19 Patients.

Stepwise Evolution of Immunodeficient Mouse Models: Focus on NCG Strains and Their Applications in Humanized Immune System Research.

Impact of the COVID-19 Pandemic on Routine Adult Vaccination in Primary Care: A Multicenter Interrupted Time Series Analysis.

Towards Precision Medicine in Inflammatory Bowel Diseases: Pharmacogenetic Predictors of Ustekinumab Effectiveness and Persistence.

Targeting HMGB1 for Renal Ischemia and Reperfusion Injury: Mechanisms and Therapeutic Strategies.

Related Experiment Videos

[Travel abroad: gammaglobulin or a vaccine against hepatitis A?]

Related Concept Videos

Related Articles